¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"DO"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 16
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • dorsal part
    µîÂʺκÐ
  • dorsal part maxillary process
    µîÂʺκРÀ§Åε¹±â
  • dorsal part of clitoris
    À½ÇÙµîÂʺκÐ
  • dorsal part of penis
    À½°æµîÂʺκÐ
  • dorsal placenta
    µîÂÊŹÝ
  • dorsal plantar artery
    ¹ßµîµ¿¸Æ
  • dorsal plate
    µîÂÊÆÇ
  • dorsal radiocarpal ligament
    µîÂʳë¼Õ¸ñÀδë
  • dorsal recess
    µîÂÊ¿À¸ñ
  • dorsal recumbent position
    ¹èµÐÀ§(ÛÎÔëêÈ).
  • dorsal reflex
    ¹è±Ù¹Ý»ç(ÛÎÐÉÚãÞÒ).
  • dorsal rhizotomy
    ¹èºÎ ½Å°æ±Ù Àý°³¼ú
  • dorsal root
    µÚ»Ñ¸®, ÈıÙ(ý­ÐÆ)
  • dorsal root ganglia
    µÚ»Ñ¸®Àý, ÈıÙÀý(ý­ÐÆï½)
  • dorsal root potential
    ÈıÙÀü¾Ð.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • double stranded helix
    ÀÌÁß»è ³ª»ç¼±
  • double suicide
    ÀÌÁß ÀÚ»ì
  • double temporal blindness
    ¾çÃøµÎ¼º ¹Ý¸Í
  • double tongue
    ÀÌ¿­¼³
    µ¿ÀǾî=bifid tongue.
  • double ureter
    °ã¿ä°ü
  • double uterus
    µÎ ÀÚ±ÃÁõ
  • double vessel disease
    ÀÌÁß °ü»ó µ¿¸Æ Áúȯ
  • double voiding
    ÀÌÁß ¹è´¢
  • double-barreled aorta
    ÀÌÁß °ü ´ëµ¿¸Æ
  • double-beam spectrophotometer
    ÀÌÁß¼± ºÐ±¤°è
  • double-blind study
    ÀÌÁß ¸Í°Ë ¿¬±¸
  • double-currnet catheter
    º¹·ùÄ«Å×ÅÍ
    ÇÑ °üÀº ¾×ü ÁÖÀÔ¿ë, ¶Ç ´Ù¸¥ ÇÑ °üÀº ¹èÃâ¿ëÀ¸·Î µÈ 2°üÀ» Áö´Ñ Ä«Å×ÅÍ.
  • double-ended curette
    ¾çµÎ Å¥·¿
  • double-ring sign
    ÀÌÁß °í¸® ¡ÈÄ
  • double-strand break
    ÀÌÁß ¼â Àý´Ü, ÀÌÁß ¿°»öºÐü ¼Õ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
Doose syndrome <syndrome> A rare familial type of primary, generalised myoclonic astatic epilepsy characterised by 2 to 3 or 4 to 6 Hz spike and wave complexes in the EEG; the condition usually responds to medication.
(05 Mar 2000)
Doose, H <person> 20th century German paediatrician and epileptologist.
See: Doose syndrome.
(05 Mar 2000)
dopa An amino acid derived from the amino acid tyrosine. It is formed as the first intermediate in the production of dopamine, a neurotransmitter.
(09 Oct 1997)
dopa decarboxylase <enzyme> One of the aromatic-l-amino-acid decarboxylases, this enzyme is responsible for the conversion of dopa to dopamine. It is of clinical importance in the treatment of parkinson's disease.
Registry number: EC 4.1.1.-
(12 Dec 1998)
DOPA dioxygenase <enzyme> Key enzyme in betalain biosynthesis pathway of amanita muscaria; genbank y12886
Registry number: EC 1.14.99.-
Synonym: dopa-4,5-dioxygenase, doda gene product
(26 Jun 1999)
dopa oxidase Provisional name given the enzyme(s) catalyzing the formation of melanins from dopa; it now appears that the copper-containing monophenol monooxygenases and/or catechol oxidases are responsible for the oxidation of l-tyrosine to dopa and dopa quinone.
(05 Mar 2000)
dopa quinone An oxidation product of dopa and an intermediate in the formation of melanin from tyrosine.
(05 Mar 2000)
dopa reaction A dark staining observed in fresh tissue sections to which a solution of dopa has been applied, presumably due to the presence of dopa oxidase in the protoplasm of certain cells.
Synonym: Bloch's reaction.
(05 Mar 2000)
dopa-responsive dystonia A condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. Segawa's dystonia is an important variant of DRD. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy.
(12 Dec 1998)
Dopa-tyrosine sulfotransferase <enzyme> Active towards tyrosine and dopa isomers except dl-ortho-tyrosine; isolated from rat liver; genbank u38419
Registry number: EC 2.8.2.-
(26 Jun 1999)
dopachrome oxidoreductase <enzyme> Decarboxylates and converts dopachrome to 5,6-dihydroxyindole; does not convert the latter to indole-5,6-quinone; found in human and mouse hairbulbs; proposed EC 5.3.2.3
Registry number: EC 5.3.2.-
Synonym: dopachrome conversion factor, indole blocking factor, dopachrome tautomerase, tyrosinase-related protein-2, trp-2, dopachrome isomerase, dopachrome conversion enzyme
(26 Jun 1999)
dopamine <drug> A catecholamine neurotransmitter and hormone (153 D), formed by decarboxylation of dehydroxyphenylalanine (dopa). A precursor of adrenaline and noradrenaline.
Pharmacologic action: 1. Precursor of norepinephrine 2. Stimulates dopaminergic, alpha and beta-1 adrenergic receptors: 3. Dopaminergic (1-2 mcg/kg per min): cerebral, renal, and mesenteric vasodilation increase urine output 4. Mixed alpha and beta-1 (2-10 mcg/kg per min): increases cardiac ouput with moderate increase systemic vascular resistance 5. Predominantly alpha (>20 mcg/kg per min): increases systemic vascular resistance
Uses: 1. Treat hypotension associated with bradycardia 2. Stimulate cardiac output and urine output
Dose: 1. Start infusion at 1-5 mcg/kg per min and titrate to effect. 2. Use the lowest dose that provides the desired hemodynamic improvement. 3. Do not exceed 20 mcg/kg per min.
Potential complications: 1. May increase pulmonary pressure and worsen pulmonary congestion. 2. May increase myocardial work without improving coronary blood flow, exacerbating myocardial ischemia 3. Stimulates heart rate and may cause supraventricular or ventricular arrhythmias
(15 Mar 2000)
dopamine agents Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
(12 Dec 1998)
dopamine agonists Drugs that bind to and activate dopamine receptors.
(12 Dec 1998)
dopamine antagonists Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (antipsychotic agents) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as antiemetics, in the treatment of tourette syndrome, and for hiccup.
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¾È±¹µ¶½ÃŬ·¹ÀÌÆ®Ä°¼¿ - »õâ
¾È±¹¾àǰ
A08502341 Doxycycline hyclate
Àü¹®ÀǾàǰ | »èÁ¦
Á߿ܵ¶½Ã½ÎÀÌŬ¸°ÇÏÀÌŬ·¹ÀÌÆ®Ä°¼¿100mg - »õâ
Áß¿Ü
A02103711 Doxycycline hyclate
Àü¹®ÀǾàǰ | ±Þ¿©
µ¿±¸µ¶½Ã»çÀÌŬ¸°ÇÏÀÌŬ·¹ÀÌÆ®Ä°¼¿ - »õâ
µ¿±¸Á¦¾à
A11101901 Doxycycline hyclate
Àü¹®ÀǾàǰ | »èÁ¦
°í·Áµ¶½Ã»çÀÌŬ¸°ÇÏÀÌŬ·¹ÀÌÆ®Ä°¼¿100mg - »õâ
°í·ÁÁ¦¾à
A15900351 Doxycycline hyclate
Àü¹®ÀǾàǰ | ±Þ¿©
ÈÞÅØ½ºµ¶½Ã»çÀÌŬ¸°ÇÏÀÌŬ·¹ÀÌÆ®Ä¸½¶ - »õâ
Çѱ¹ÈÞÅØ½ºÁ¦¾à
A00801461 Doxycycline hyclate
Àü¹®ÀǾàǰ | ±Þ¿©
È޿½ºµ¶½Ã»çÀÌŬ¸°ÇÏÀÌŬ·¹ÀÌÆ®Ä°¼¿100mg - »õâ
È޿½º
A29550141 Doxycycline hyclate
Àü¹®ÀǾàǰ | ±Þ¿©
¸ð³ë½Å°ÇÁ¶½Ã·´ - »õâ
°í·ÁÁ¦¾à
A15900431 Doxycycline hyclate
Àü¹®ÀǾàǰ | »èÁ¦
µ¶½Ã½º·£¼­¹æÄ°¼¿ - »õâ
µ¿½ÅÁ¦¾à
A15106311 Doxycycline hyclate s.r.
Àü¹®ÀǾàǰ | »èÁ¦
µ¶½Ã·¿Ä°¼¿ - »õâ
À¯¿µÁ¦¾à
A34002561 Doxycycline hyclate s.r.
Àü¹®ÀǾàǰ | »èÁ¦
º¸·Éµµ¸¯½ºÄ°¼¿100mg - »õâ
º¸·ÉÁ¦¾à
A09303081 Doxycycline hyclate s.r.
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
dorsum back: the posterior part of a human (or animal) body from the neck to the end of the spine; "his back was nicely tanned" the back of the body of a vertebrate or any analogous surface (as the upper or outer surface of an organ or appendage or part); "the dorsum of the foot"
Ãâó: wordnet.princeton.edu/perl/webwn
downer sedative: a drug that reduces excitability and calms a person
Ãâó: wordnet.princeton.edu/perl/webwn
doxepin hydrochloride doxepin: a tricyclic antidepressant (trade names Adapin and Sinequan) with numerous side effects (dry mouth and sedation and gastrointestinal disturbances)
Ãâó: wordnet.princeton.edu/perl/webwn
doxorubicin an antibiotic used as an anticancer drug
Ãâó: wordnet.princeton.edu/perl/webwn
dosage dose: the quantity of an active agent (substance or radiation) taken in or absorbed at any one time
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • doh
    =DO
  • Doha
    µµÇÏ(QatarÀÇ ¼öµµ)
  • doily
    µµÀϸ®(²Éº´ µûÀ§ ¹Þħ¿ëÀÇ ·¹À̽º ¶Ç´Â Á¾ÀÌ ³ÀŲ)
  • doing
    ÇàÇÔ
  • doing
    ÇàÀ§;½ÇÇà;¼ÒÇà;Çൿ
  • doit
    ¿¾³×´ú¶õµåÀǵ¿Àü
  • doited
    (½ºÄÚ)³ë¸ÁÇÑ
  • doityourself
    ¼Õ¼öÇÏ´Â;ÀÚÀÛÀÇ
  • doityourselfer
    ¼Õ¼ö ¸¸µå´Â »ç¶÷
  • Dol
    (¿©ÀÚÀ̸§)
  • dol,
    dollar
  • Dolby system
    µ¹ºñ¹æ½Ä(³ìÀ½ Å×ÀÌÇÁÀÇ ÀâÀ½À» ÁÙÀÌ´Â ¹æ¹ý)
  • Dolbyized
    µ¹ºñ ¹æ½ÄÀÇ
  • dolce
    ´ÞÄÞÇÑ;°¨¹Ì·Î¿î
  • dolce far niente
    ¾ÈÀÏ;À϶ô 
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 16
DO common grass with slender stems and narrow leaves
DO a hard biscuit for dogs
DO a bite inflicted by a dog
DO breeding dogs
DO an employee of a municipal pound who is hired to round up stray dogs and cats
DO necklace that fits tightly around a woman's neck
DO a stiff white collar with no opening in the front
DO a collar for a dog
DO the hot period between early July and early September
DO fecal droppings from a dog
DO widespread rank-smelling weed having white-rayed flower heads with yellow discs
DO weedy plant of southeastern United States having divided leaves and long clusters of greenish flowers
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 16
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á